A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00679991
Recruitment Status : Completed
First Posted : May 19, 2008
Last Update Posted : April 30, 2015
Information provided by (Responsible Party):
Proteon Therapeutics